| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| H0015 |
Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education |
13,369 |
4,412 |
$2.11M |
| H0006 |
Alcohol and/or drug services; case management |
25,427 |
10,130 |
$1.03M |
| H0038 |
Self-help/peer services, per 15 minutes |
11,990 |
2,914 |
$674K |
| H0048 |
Alcohol and/or other drug testing: collection and handling only, specimens other than blood |
41,399 |
11,386 |
$580K |
| H0005 |
Alcohol and/or drug services; group counseling by a clinician |
10,766 |
3,654 |
$380K |
| 90837 |
Psychotherapy, 53 minutes with patient |
3,853 |
1,913 |
$372K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
6,088 |
2,840 |
$290K |
| T1003 |
Lpn/lvn services, up to 15 minutes |
7,011 |
3,932 |
$168K |
| 90834 |
Psychotherapy, 45 minutes with patient |
2,329 |
1,517 |
$154K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,486 |
3,257 |
$152K |
| 90832 |
Psychotherapy, 30 minutes with patient |
2,710 |
1,709 |
$139K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
3,755 |
1,883 |
$78K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
399 |
369 |
$41K |
| 80361 |
|
1,715 |
1,131 |
$28K |
| 80346 |
|
1,409 |
901 |
$27K |
| 80363 |
|
1,405 |
900 |
$23K |
| 90791 |
Psychiatric diagnostic evaluation |
230 |
216 |
$22K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
262 |
242 |
$21K |
| 80348 |
|
1,866 |
1,210 |
$16K |
| 80354 |
|
1,829 |
1,134 |
$16K |
| 80355 |
|
1,731 |
1,138 |
$15K |
| 80365 |
|
1,713 |
1,130 |
$15K |
| 80358 |
|
1,711 |
1,130 |
$15K |
| 80373 |
|
1,712 |
1,132 |
$15K |
| 80366 |
|
1,712 |
1,132 |
$15K |
| 80349 |
|
1,623 |
1,056 |
$15K |
| 80360 |
|
1,578 |
1,044 |
$15K |
| T1002 |
Rn services, up to 15 minutes |
392 |
157 |
$14K |
| 80356 |
|
1,366 |
915 |
$13K |
| 80372 |
|
1,407 |
901 |
$13K |
| 80362 |
|
361 |
276 |
$6K |
| 80347 |
|
269 |
209 |
$5K |
| 90785 |
|
446 |
223 |
$5K |
| 83992 |
|
261 |
159 |
$3K |
| 80325 |
|
268 |
208 |
$3K |
| 80369 |
|
268 |
208 |
$3K |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
20 |
20 |
$2K |
| 80353 |
|
269 |
163 |
$2K |
| 80324 |
|
267 |
164 |
$2K |
| 80345 |
|
261 |
159 |
$2K |
| 80359 |
|
261 |
159 |
$2K |
| 80336 |
|
261 |
159 |
$2K |
| 80368 |
|
261 |
159 |
$2K |
| 80370 |
|
260 |
159 |
$2K |
| 82075 |
|
96 |
52 |
$1K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
44 |
37 |
$865.20 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
14 |
12 |
$846.70 |
| 80323 |
|
82 |
40 |
$570.18 |
| 90875 |
|
109 |
59 |
$0.00 |